Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02301117
Title A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | CZE

Facility Status City State Zip Country Details
Phoenix Clinical Site Phoenix Arizona 85054 United States Details
Duarte Clinical Site Duarte California 91010 United States Details
Santa Monica Clinical Site Santa Monica California 90095 United States Details
Gainesville Clinical Site Gainesville Florida 32610 United States Details
Baltimore Clinical Site Baltimore Maryland 21231 United States Details
Boston Clinical Site Boston Massachusetts 02111 United States Details
Cleveland Clinical Site Cleveland Ohio 44106 United States Details
Cleveland Clinical Site Cleveland Ohio 44195 United States Details
Pittsburgh Clinical Site Pittsburgh Pennsylvania 15232 United States Details
Dallas Clinical Site Dallas Texas 75246 United States Details
Brno Clinical Site Brno Czechia Details
Praha Clinical Site Praha Czechia Details
Belgrade Clinical Site Belgrade 11080 Serbia Details
Sremska Kamenica Clinical Site Sremska Kamenica 21204 Serbia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field